Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00432991 · ClinicalTrials.gov registry record · Phase 2
Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT00432991 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 53 participants.
The verdict
NCT00432991, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
The purpose of this research study is to investigate if the incidence of nausea and vomiting that subjects experience during and after a Cesarean section can be reduced by giving a shot of the drug ephedrine into the thigh muscle at the time of spinal anesthesia administration.
Interventions
- DRUG Saline Placebo
- DRUG Ephedrine [Synonyms: Ephedra, Ephedrinum]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00432991
The ClinicalTrials.gov registry entry for NCT00432991 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Placebo is the first listed.
NCT00432991 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00432991 about?
NCT00432991 is a clinical study titled "Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section". The purpose of this research study is to investigate if the incidence of nausea and vomiting that subjects experience during and after a Cesarean section can be reduced by giving a shot of the drug ephedrine into the thigh muscle at the time of spinal anesthesia administration.
What is the current status of trial NCT00432991?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2007-02. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00432991?
The interventions under investigation include: Saline Placebo (DRUG), Ephedrine [Synonyms: Ephedra, Ephedrinum] (DRUG).
Who is sponsoring clinical trial NCT00432991?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.